Literature DB >> 16000642

Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?

S Buhner1, C Buning, J Genschel, K Kling, D Herrmann, A Dignass, I Kuechler, S Krueger, H H-J Schmidt, H Lochs.   

Abstract

BACKGROUND AND AIMS: A genetically impaired intestinal barrier function has long been suspected to be a predisposing factor for Crohn's disease (CD). Recently, mutations of the capsase recruitment domain family, member 15 (CARD15) gene have been identified and associated with CD. We hypothesise that a CARD15 mutation may be associated with an impaired intestinal barrier.
METHODS: We studied 128 patients with quiescent CD, 129 first degree relatives (CD-R), 66 non-related household members (CD-NR), and 96 healthy controls. The three most common CARD15 polymorphisms (R702W, G908R, and 3020insC) were analysed and intestinal permeability was determined by the lactulose/mannitol ratio.
RESULTS: Intestinal permeability was significantly increased in CD and CD-R groups compared with CD-NR and controls. Values above the normal range were seen in 44% of CD and 26% of CD-R but only in 6% of CD-NR, and in none of the controls. A household community with CD patients, representing a common environment, was not associated with increased intestinal permeability in family members. However, 40% of CD first degree relatives carrying a CARD15 3020insC mutation and 75% (3/4) of those CD-R with combined 3020insC and R702W mutations had increased intestinal permeability compared with only 15% of wild-types, indicating a genetic influence on barrier function. R702W and G908R mutations were not associated with high permeability.
CONCLUSIONS: In healthy first degree relatives, high mucosal permeability is associated with the presence of a CARD15 3020insC mutation. This indicates that genetic factors may be involved in impairment of intestinal barrier function in families with IBD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000642      PMCID: PMC1856071          DOI: 10.1136/gut.2005.065557

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  Clustering of increased small intestinal permeability in families with Crohn's disease.

Authors:  M Peeters; B Geypens; D Claus; H Nevens; Y Ghoos; G Verbeke; F Baert; S Vermeire; R Vlietinck; P Rutgeerts
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

2.  Permeability in Crohn's disease: altered barrier functions in healthy relatives?

Authors:  D Hollander
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

3.  Intestinal permeability in patients with Crohn's disease and their first degree relatives.

Authors:  K Teahon; P Smethurst; A J Levi; I S Menzies; I Bjarnason
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

4.  Intestinal permeability in patients with Crohn's disease and their healthy relatives.

Authors:  K D Katz; D Hollander; C M Vadheim; C McElree; T Delahunty; V D Dadufalza; P Krugliak; J I Rotter
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

5.  The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.

Authors:  J P Van de Merwe; A M Schröder; F Wensinck; M P Hazenberg
Journal:  Scand J Gastroenterol       Date:  1988-11       Impact factor: 2.423

6.  Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability.

Authors:  S Buhner; I Reese; F Kuehl; H Lochs; T Zuberbier
Journal:  Allergy       Date:  2004-10       Impact factor: 13.146

7.  Intestinal permeability and the prediction of relapse in Crohn's disease.

Authors:  J Wyatt; H Vogelsang; W Hübl; T Waldhöer; H Lochs
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

8.  Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.

Authors:  C Büning; J Genschel; S Bühner; S Krüger; K Kling; A Dignass; P Baier; B Bochow; J Ockenga; H H-J Schmidt; H Lochs
Journal:  Aliment Pharmacol Ther       Date:  2004-05-15       Impact factor: 8.171

9.  Is small intestinal permeability really increased in relatives of patients with Crohn's disease?

Authors:  G R May; L R Sutherland; J B Meddings
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

10.  CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.

Authors:  B R Yacyshyn; J B Meddings
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

View more
  122 in total

1.  The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.

Authors:  Matthias Prager; Janine Büttner; Verena Haas; Daniel C Baumgart; Andreas Sturm; Martin Zeitz; Carsten Büning
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

2.  Bin1: a new player in IBD barrier dysfunction.

Authors:  Hyunji Ryu; Daniela Posca; Terrence Barrett
Journal:  Dig Dis Sci       Date:  2012-05-30       Impact factor: 3.199

Review 3.  Myosin light chain kinase: pulling the strings of epithelial tight junction function.

Authors:  Kevin E Cunningham; Jerrold R Turner
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 4.  Tight junctions on the move: molecular mechanisms for epithelial barrier regulation.

Authors:  Le Shen
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.

Authors:  Matthias Jürgens; Stephan Brand; Rüdiger P Laubender; Julia Seiderer; Jürgen Glas; Martin Wetzke; Johanna Wagner; Simone Pfennig; Cornelia Tillack; Florian Beigel; Maria Weidinger; Fabian Schnitzler; Martin E Kreis; Burkhard Göke; Peter Lohse; Karin Herrmann; Thomas Ochsenkühn
Journal:  J Gastroenterol       Date:  2010-04-29       Impact factor: 7.527

Review 6.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

7.  Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.

Authors:  Xiaochang Liu; Jianming Xu; Qiao Mei; Liang Han; Jian Huang
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

Review 8.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

9.  LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.

Authors:  Brad T Schwarz; Fengjun Wang; Le Shen; Daniel R Clayburgh; Liping Su; Yingmin Wang; Yang-Xin Fu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2007-02-27       Impact factor: 22.682

Review 10.  Novel biomarkers of fibrosis in Crohn's disease.

Authors:  Gianluca Pellino; Pierlorenzo Pallante; Francesco Selvaggi
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.